| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000029282 |
| Receipt No. | R000033470 |
| Official scientific title of the study | Sentinel lymph node biopsy for early stage cervical cancer. |
| Date of disclosure of the study information | 2017/10/01 |
| Last modified on | 2017/10/12 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Sentinel lymph node biopsy for early stage cervical cancer. | |
| Title of the study (Brief title) | Sentinel lymph node biopsy for early stage cervical cancer. | |
| Region |
|
|
| Condition | |||
| Condition | cervical cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To investigate the feasibility and prognosis of sentinel lymph node biopsy for stage 1a2-2 cervical cancer. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | over all survival |
| Key secondary outcomes | 5 year survival
progression free survival detection rate of sentinel lymph node negative predictive value |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | |
| Concealment | |
| Intervention | ||||
| No. of arms | 1 | |||
| Purpose of intervention | Treatment | |||
| Type of intervention |
|
|||
| Interventions/Control_1 | 1. Cervical injection of 99m Tc - phytate (55-70MBq) on 3-6-9-12 o`clock position.
2. Lymphoscintigraphy (15:00 the day before surgery) 3. Lymphoscintigraphy (8:00 the operation day) 4. Cervical injection of 1% patent blue (each 1ml) or ICG (each 1ml) on 3-6-9-12 oclock position. 5. SNL detection with RI probe (Navigator ) and blue dye or ICG. 6. Intraoperative pathologic daiagnosis. 7. Pelvic lymphadenectomy SLN metastasis(+), not detecting SLN: systemic lymphadenectomy SLN metastasis(-): SLN biopsy |
|||
| Interventions/Control_2 | ||||
| Interventions/Control_3 | ||||
| Interventions/Control_4 | ||||
| Interventions/Control_5 | ||||
| Interventions/Control_6 | ||||
| Interventions/Control_7 | ||||
| Interventions/Control_8 | ||||
| Interventions/Control_9 | ||||
| Interventions/Control_10 | ||||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Early stage (1A2-2) cervical cancer
Squamous cell carcinoma, adenocarcinoma ECOG Performance Status,0-1 |
|||
| Key exclusion criteria | Patient with pelvic lymeph node metastasis on imaging.
Pataients with severe complications. The patients who are unappropriate for this study judged by the physician. |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Toshihiro Higuchi |
| Organization | Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital |
| Division name | Department of Obstetrics and Gynecology |
| Address | 2-4-20 Ohgimachi,Kita-ku,Osaka,JAPAN,530-8480 |
| TEL | 06-6312-1221 |
| ts-higuchi@kitano-hp.or.jp | |
| Public contact | |
| Name of contact person | Natsuki Tsuji |
| Organization | Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital |
| Division name | Department of Obstetrics and Gynecology |
| Address | 2-4-20 Ohgimachi,Kita-ku,Osaka,JAPAN,530-8480 |
| TEL | 06-6312-1221 |
| Homepage URL | |
| n-tsuzi@kitano-hp.or.jp | |
| Sponsor | |
| Institute | Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 田附興風会医学研究所 北野病院(大阪府) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033470 |